Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerorsis

Explore clinical trials studying Relapsing Multiple Sclerorsis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerorsis trial results

Completed

Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

NCT02688985

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Yale University School of Medicine ; Pulmonary & Critical Care New Haven, Connecticut, United States
View all 17 locations
View Trial Details

Related conditions